Pennant Group, Inc. (PNTG) shareholders
Close on Nov 17, 2026Market cap $1.27BP/E 40.6Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Van Berkom & Associates Inc. | 3,112,812 | 9.00% | 13G (passive) amendment | Sep 30, 2025 |
| Scott Green Joint filing with 8 Knots Management, LLC (7.70%) | 2,652,806 | 7.70% | 13G (passive) amendment | Jun 30, 2025 |
| BlackRock, Inc. | 2,184,974 | 7.30% | 13G (passive) amendment | Dec 31, 2023 |
| Wasatch Advisors LP | 1,870,178 | 5.40% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PNTG | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2,959,141 | 8.47% | $109.34M | +243,076 | 0.00% |
| Van Berkom & Associates Inc. | 2,369,269 | 6.78% | $87.54M | −2,969,599 | 2.82% |
| Wasatch Advisors LP | 1,870,178 | 5.35% | $69.10M | +451,491 | 0.45% |
| Turtle Creek Asset Management Inc. | 1,714,462 | 4.91% | $63.35M | +131,639 | 2.47% |
| Vanguard Capital Management LLC | 1,480,881 | 4.24% | $54.72M | +29,913 | 0.00% |
| Paradigm Capital Management Inc/Ny | 1,402,800 | 4.02% | $51.83M | −6,000 | 1.41% |
| FMR LLC | 1,182,138 | 3.38% | $43.68M | +79,514 | 0.00% |
| First Eagle Investment Management, LLC | 1,141,000 | 3.27% | $42.16M | +710,000 | 0.03% |
| Provident Investment Management, Inc. | 939,208 | 2.69% | $34.70M | −43,807 | 3.37% |
| Goldman Sachs Group Inc | 891,426 | 2.55% | $32.94M | +260,035 | 0.00% |
| Geode Capital Management, LLC | 886,783 | 2.54% | $32.77M | +44,645 | 0.00% |
| Ameriprise Financial Inc | 874,745 | 2.50% | $32.32M | +2,560 | 0.01% |
| State Street Corp | 873,014 | 2.50% | $32.26M | +69,234 | 0.00% |
| Dimensional Fund Advisors LP | 868,516 | 2.49% | $32.09M | +52,856 | 0.01% |
| Wellington Management Group Llp | 757,608 | 2.17% | $27.99M | −190 | 0.00% |
| Nuveen, LLC | 699,830 | 2.00% | $25.86M | +4,924 | 0.01% |
| Morgan Stanley | 544,936 | 1.56% | $20.14M | +12,653 | 0.00% |
| Boone Capital Management LLC | 515,818 | 1.48% | $19.06M | New | 4.46% |
| De Lisle Partners LLP | 507,977 | 1.45% | $18.75M | – | 2.05% |
| Eversept Partners, LP | 460,272 | 1.32% | $17.01M | +148,094 | 0.88% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 203 | 32M | 92.7% | 39 / 62 | 68 / 22 | 4M | 6M |
| Q1 2026 | 189 | 34M | 96.7% | 31 / 62 | 67 / 25 | 9M | 4M |
| Q4 2025 | 187 | 31M | 88.3% | 26 / 62 | 66 / 22 | 4M | 4M |
| Q3 2025 | 190 | 31M | 89.6% | 44 / 58 | 60 / 27 | 7M | 6M |
| Q2 2025 | 174 | 31M | 88.7% | 24 / 59 | 58 / 29 | 3M | 3M |
| Q1 2025 | 181 | 30M | 86.9% | 24 / 61 | 62 / 23 | 4M | 3M |
| Q4 2024 | 181 | 30M | 87.0% | 37 / 71 | 51 / 24 | 7M | 3M |
| Q3 2024 | 171 | 26M | 75.4% | 38 / 50 | 55 / 15 | 5M | 2M |
| Q2 2024 | 151 | 26M | 74.6% | 24 / 54 | 50 / 18 | 3M | 3M |
| Q1 2024 | 147 | 26M | 75.8% | 19 / 46 | 62 / 14 | 3M | 3M |
| Q4 2023 | 143 | 26M | 74.1% | 26 / 44 | 49 / 9 | 4M | 3M |
| Q3 2023 | 126 | 24M | 69.2% | 7 / 46 | 48 / 14 | 1M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
206 funds held PNTG in Q2 2026, 34% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of PNTG | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,049,539 | 3.00% | $38.78M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 880,412 | 2.52% | $32.53M | 0.04% | Jun 30, 2026 |
| Columbia Acorn Fund | 699,307 | 2.00% | $25.84M | 0.93% | Jun 30, 2026 |
| Wasatch Small Cap Growth Fund | 648,180 | 1.86% | $23.95M | 2.03% | Jun 30, 2026 |
| First Eagle Small Cap Opportunity Fund | 517,208 | 1.48% | $20.85M | 0.72% | Jul 31, 2026 |
| Wasatch Micro Cap Fund | 484,039 | 1.39% | $17.89M | 2.65% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 396,035 | 1.13% | $14.63M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 372,792 | 1.07% | $15.03M | 0.04% | Jul 31, 2026 |
| College Retirement Equities Fund - Total Global Stock Account | 358,473 | 1.03% | $13.25M | 0.01% | Jun 30, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 353,420 | 1.01% | $12.10M | 0.00% | May 31, 2026 |
| iShares Russell 2000 Growth ETF | 320,466 | 0.92% | $11.84M | 0.08% | Jun 30, 2026 |
| Victory RS Partners Fund | 276,070 | 0.79% | $10.20M | 1.50% | Jun 30, 2026 |
| Fidelity Small Cap Discovery Fund | 268,668 | 0.77% | $10.83M | 0.48% | Jul 31, 2026 |
| Fidelity Series Small Cap Discovery Fund | 241,080 | 0.69% | $9.72M | 0.50% | Jul 31, 2026 |
| Nuveen Quant Small Cap Equity Fund | 197,780 | 0.57% | $7.97M | 0.20% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| John J. Gochnour | Chief Operating Officer | 144,788 | 0.41% | Oct 27, 2026 |
| Brent Guerisoli | Chief Executive Officer | 99,544 | 0.28% | Aug 10, 2026 |
| Jason Paul Steik | Chief Clinical Officer | 15,106 | 0.04% | Aug 10, 2026 |
| Kirk Sterling Cheney | EVP, GC and Corp Secy | 18,401 | 0.05% | Aug 10, 2026 |
| Lynette Walbom | Chief Financial Officer | 10,688 | 0.03% | Apr 17, 2026 |
| Barry M. Smith | Director | 99,299 | 0.28% | Nov 13, 2026 |
| Gregory K. Morris Sr. | Director | 39,200 | 0.11% | Oct 19, 2026 |
| John G. Nackel | Director | 179,165 | 0.51% | Oct 19, 2026 |
| Scott E. Lamb | Director | 61,335 | 0.18% | Oct 19, 2026 |
| Suzanne D. Snapper | Director | 232,264 | 0.66% | Oct 19, 2026 |
| Christopher R. Christensen | Director | 771,238 | 2.21% | Oct 19, 2026 |
| Stephen M. R. Covey | Director | 45,950 | 0.13% | Oct 19, 2026 |
| JoAnne Stringfield | Director | 30,275 | 0.09% | May 23, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Barry M. Smith Director | Nov 10, 2026 | Gift | −5,100 | $36.74 | $187.37K | 99,299 |
| John J. Gochnour Chief Operating Officer | Oct 23, 2026 | Tax withholding | −6,624 | $42.05 | $278.51K | 144,788 |
| John J. Gochnour Chief Operating Officer | Oct 23, 2026 | Option exercise | +5,948 | $6.10 | $36.28K | 151,412 |
| Gregory K. Morris Sr. Director | Oct 15, 2026 | Award | +1,900 | – | – | 39,200 |
| Suzanne D. Snapper Director | Oct 15, 2026 | Award | +1,900 | – | – | 232,264 |
| John G. Nackel Director | Oct 15, 2026 | Award | +1,900 | – | – | 176,465 |
| Christopher R. Christensen Director | Oct 15, 2026 | Award | +1,900 | – | – | 147,891 |
| Scott E. Lamb Director | Oct 15, 2026 | Award | +2,400 | – | – | 61,335 |
| Barry M. Smith Director | Oct 15, 2026 | Award | +1,900 | – | – | 104,399 |
| Stephen M. R. Covey Director | Oct 15, 2026 | Award | +1,900 | – | – | 45,950 |
| Brent Guerisoli Chief Executive Officer | Aug 6, 2026 | Sale(10b5-1 plan) | −4,285 | $38.52 | $165.06K | 99,544 |
| Kirk Sterling Cheney EVP, GC and Corp Secy | Aug 6, 2026 | Sale(10b5-1 plan) | −1,393 | $38.52 | $53.66K | 18,401 |
| Jason Paul Steik Chief Clinical Officer | Aug 6, 2026 | Sale(10b5-1 plan) | −1,394 | $38.52 | $53.70K | 15,106 |
| Barry M. Smith Director | Jul 15, 2026 | Award | +1,900 | – | – | 102,499 |
| Gregory K. Morris Sr. Director | Jul 15, 2026 | Award | +1,900 | – | – | 37,300 |
| Christopher R. Christensen Director | Jul 15, 2026 | Award | +1,900 | – | – | 145,991 |
| Suzanne D. Snapper Director | Jul 15, 2026 | Award | +1,900 | – | – | 230,364 |
| Scott E. Lamb Director | Jul 15, 2026 | Award | +2,400 | – | – | 58,935 |
| John G. Nackel Director | Jul 15, 2026 | Award | +1,900 | – | – | 174,565 |
| Stephen M. R. Covey Director | Jul 15, 2026 | Award | +1,900 | – | – | 44,050 |
| Brent Guerisoli Chief Executive Officer | Jul 10, 2026 | Sale(10b5-1 plan) | −3,159 | $41.57 | $131.32K | 103,829 |
| Brent Guerisoli Chief Executive Officer | Jul 10, 2026 | Option exercise | +6,248 | $4.54 | $28.37K | 106,988 |
| Brent Guerisoli Chief Executive Officer | Jul 7, 2026 | Sale(10b5-1 plan) | −3,165 | $40.51 | $128.21K | 100,740 |
| Brent Guerisoli Chief Executive Officer | Jul 7, 2026 | Option exercise | +6,249 | $4.54 | $28.37K | 103,905 |
| Brent Guerisoli Chief Executive Officer | May 22, 2026 | Sale(10b5-1 plan) | −2,032 | $35.08 | $71.28K | 95,647 |
| Brent Guerisoli Chief Executive Officer | May 22, 2026 | Sale(10b5-1 plan) | −22 | $34.86 | $767 | 97,679 |
| Brent Guerisoli Chief Executive Officer | May 22, 2026 | Sale(10b5-1 plan) | −2,254 | $35.08 | $79.07K | 97,656 |
| Brent Guerisoli Chief Executive Officer | May 22, 2026 | Option exercise | +4,463 | $3.84 | $17.14K | 97,701 |
| Brent Guerisoli Chief Executive Officer | May 22, 2026 | Option exercise | +4,463 | $3.84 | $17.14K | 99,910 |
| Brent Guerisoli Chief Executive Officer | May 22, 2026 | Sale(10b5-1 plan) | −200 | $35.10 | $7.02K | 95,447 |
| Christopher R. Christensen Director | Apr 15, 2026 | Award | +1,900 | – | – | 144,091 |
| Stephen M. R. Covey Director | Apr 15, 2026 | Award | +1,900 | – | – | 42,150 |
| Barry M. Smith Director | Apr 15, 2026 | Award | +1,900 | – | – | 100,599 |
| Gregory K. Morris Sr. Director | Apr 15, 2026 | Award | +1,900 | – | – | 35,400 |
| Suzanne D. Snapper Director | Apr 15, 2026 | Award | +1,900 | – | – | 228,464 |
| John G. Nackel Director | Apr 15, 2026 | Award | +1,900 | – | – | 172,665 |
| Scott E. Lamb Director | Apr 15, 2026 | Award | +2,400 | – | – | 56,535 |
| John J. Gochnour Chief Operating Officer | Mar 3, 2026 | Award | +11,214 | – | – | 145,464 |
| Kirk Sterling Cheney EVP, GC and Corp Secy | Mar 3, 2026 | Award | +2,874 | – | – | 19,794 |
| Lynette Walbom Chief Financial Officer | Mar 3, 2026 | Award | +8,025 | – | – | 10,688 |
| Brent Guerisoli Chief Executive Officer | Mar 3, 2026 | Award | +11,260 | – | – | 93,238 |
| John J. Gochnour Chief Operating Officer | Mar 3, 2026 | Award | +18,565 | – | – | 152,815 |
| Lynette Walbom Chief Financial Officer | Mar 3, 2026 | Award | +14,292 | – | – | 16,955 |
| Kirk Sterling Cheney EVP, GC and Corp Secy | Mar 3, 2026 | Award | +4,085 | – | – | 21,005 |
| Brent Guerisoli Chief Executive Officer | Mar 3, 2026 | Award | +20,052 | – | – | 102,030 |
| Gregory K. Morris Sr. Director | Jan 15, 2026 | Award | +1,900 | – | – | 33,500 |
| Stephen M. R. Covey Director | Jan 15, 2026 | Award | +1,900 | – | – | 40,250 |
| John G. Nackel Director | Jan 15, 2026 | Award | +1,900 | – | – | 170,765 |
| Suzanne D. Snapper Director | Jan 15, 2026 | Award | +1,900 | – | – | 226,564 |
| Christopher R. Christensen Director | Jan 15, 2026 | Award | +1,900 | – | – | 142,191 |
| Scott E. Lamb Director | Jan 15, 2026 | Award | +2,400 | – | – | 54,135 |
| Barry M. Smith Director | Jan 15, 2026 | Award | +1,900 | – | – | 98,699 |
| Kirk Sterling Cheney EVP, GC and Corp Secy | Nov 11, 2025 | Option exercise | +3,800 | $15.09 | $57.34K | 16,920 |
| Suzanne D. Snapper Director | Oct 15, 2025 | Award | +1,900 | – | – | 224,664 |
| John G. Nackel Director | Oct 15, 2025 | Award | +1,900 | – | – | 168,865 |
| Stephen M. R. Covey Director | Oct 15, 2025 | Award | +1,900 | – | – | 38,350 |
| Scott E. Lamb Director | Oct 15, 2025 | Award | +2,400 | – | – | 51,735 |
| Gregory K. Morris Sr. Director | Oct 15, 2025 | Award | +1,900 | – | – | 31,600 |
| Christopher R. Christensen Director | Oct 15, 2025 | Award | +1,900 | – | – | 140,291 |
| Barry M. Smith Director | Oct 15, 2025 | Award | +1,900 | – | – | 96,799 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Pennant's stock actually held short. Settlement fails (shares not delivered on time) peaked at 15,428 shares on Oct 9, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Kirk Sterling Cheney Officer | Aug 6, 2026 | 1,393 | $53.66K | Aug 6, 2026 | Restricted Stock Vesting |
| Brent Guerisoli Officer, Director | Aug 6, 2026 | 4,285 | $165.07K | Aug 6, 2026 | Restricted Stock Vesting |
| Jason Paul Steik Officer | Aug 6, 2026 | 1,394 | $53.70K | Aug 6, 2026 | Restricted Stock Vesting |
| Brent Guerisoli Officer, Director | Jul 10, 2026 | 3,159 | $131.30K | Jul 10, 2026 | Stock Option Exercise |
| Brent Guerisoli Officer, Director | Jul 7, 2026 | 3,165 | $128.21K | Jul 7, 2026 | Stock Option Exercise |
| Brent Guerisoli Officer, Director | May 22, 2026 | 4,508 | $158.14K | May 22, 2026 | Options Granted - 05/26/2016 |
| John J. Gochnour Officer | May 14, 2026 | 4,639 | $170.68K | May 14, 2026 | Options Granted - 05/26/2016 |
| Brent Guerisoli Officer, Director | Jul 28, 2025 | 3,995 | $93.23K | Jul 28, 2025 | Restricted Stock Vesting |
| Brent Guerisoli Officer, Director | Jul 28, 2025 | 3,995 | $93.23K | Jul 28, 2025 | Restricted Stock Vesting |
| JoAnne Stringfield Director | May 20, 2025 | 11,954 | $351.79K | May 20, 2025 | Restricted Stock Vesting |
| JoAnne Stringfield Director | May 1, 2025 | 665 | $17.04K | May 1, 2025 | Restricted Stock Vesting |
| JoAnne Stringfield Director | Jan 30, 2025 | 665 | $18.54K | Jan 30, 2025 | Restricted Stock Vesting |
| JoAnne Stringfield Director | Oct 23, 2024 | 380 | $12.75K | Oct 23, 2024 | Restricted Stock Vesting |
| Brent Guerisoli Officer, Director | Aug 27, 2024 | 1,418 | $49.26K | Aug 27, 2024 | Option Granted- 05/27/2015 |
| Brent Guerisoli Officer, Director | Jul 29, 2024 | 3,901 | $116.50K | Jul 29, 2024 | Restricted Stock Vesting |
See a number that looks wrong?